Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr-Jun;12(2):113-122.
doi: 10.25122/jml-2018-0075.

A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease

Affiliations
Review

A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease

Seyed Saeid Seyedian et al. J Med Life. 2019 Apr-Jun.

Abstract

Ulcerative colitis (UC) and Crohn's disease (CD) are classified as chronic inflammatory bowel diseases (IBD) which have similar symptoms and lead to digestive disorders and inflammation in the digestive system. The reason why they occur is still a mystery. A number of factors can be attributed to the prevalence of CD and UC, some of which include geographical location, inappropriate diet, genetics, and inappropriate immune response. Both diseases are more often diagnosed in urban areas compared to rural areas and both have their own challenges and side effects, but the patients can still have a good quality of life. Given the fact that the prevalence of this disease is higher at younger ages and that it disrupts half the life of the patient, it will, most likely, become a major health problem in the near future, even in developing countries. By reviewing valid scientific resources and evaluating new methods of addressing this disease, the present study aims to provide researchers and patients with new insights into this field and facilitate access to new treatments.

Keywords: Crohn’s disease (CD); IBD treatment; Inflammatory Bowel Disease (IBD); ulcerative colitis (UC).

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Treatment proposed by Mesuri et al. (1994) for Crohn’s disease.

Similar articles

Cited by

References

    1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving treatments. The Lancet. 2007;369(9573):1641–57. - PubMed
    1. Gryboski JD. Ulcerative colitis in children 10 years old or younger. J Pediatr Gastroenterol Nutr. 1993;17:24–31. - PubMed
    1. Hugot JP, Corinne A, Dominique B, Edouard B, Cezard JP. Crohn’s disease: the cold chain hypothesis. Lancet. 2003;362:2012–15. - PubMed
    1. Burgmann T, Clara I, Graft L, Walker J, Lix L, Rawsthorne P, et al. The Manitoba Inflammatory Bowel Disease Cohort study: Prolonged symptoms before diagnosishow much is irritable bowel syndrome? Clin Gastroenterol Hepatol. 2006;4:614–20. - PubMed
    1. Farmer RG, Hawk WA, Turnbull RB., Jr. Clinical patterns in Crohn’s disease: A statistical study of 615 cases. Gastroenterology. 1975;68:627–35. - PubMed

MeSH terms

LinkOut - more resources